Results 101 to 110 of about 13,503 (207)

Allicin Alleviates Inflammation of Trinitrobenzenesulfonic Acid-Induced Rats and Suppresses P38 and JNK Pathways in Caco-2 Cells

Mediators of Inflammation, 2015
Background. Allicin has anti-inflammatory, antioxidative and proapoptotic properties. Aims. To evaluate the effects and investigate the mechanism of allicin on trinitrobenzenesulfonic acid-induced colitis, specifically with mesalazine or sulfasalazine ...
Chen Li, Weijian Lun, Xinmei Zhao, Shan Lei, Yandong Guo, Jiayi Ma, Fachao Zhi   +6 more
doaj   +1 more source

Development and Characterization of Eudragit RS 100 Loaded Microsponges and its Colonic Delivery Using Natural Polysaccharides [PDF]

, 2009
In the present work, paracetamol loaded eudragit based microsponges were prepared using quasi-emulsion solvent diffusion method. The compatibility of the drug with various formulation components was established.
Ranjit Singh, Vikas Jain
core   +2 more sources

Investigation of Possible Positive Effects of Arbutin Application in Experimental Colitis Model

The Turkish Journal of Gastroenterology
Background/Aims: This study aimed to investigate the possible positive effects of arbutin in a trinitrobenzene sulfonic acid (TNBS)- induced experimental colitis model, to compare it with mesalazine, which is used in treating inflammatory bowel disease ...
Merve Bıyıklı Alemdar, Ferhat Şirinyıldız, Adil Coşkun, İbrahim Meteoğlu, İsmail Taşkıran, Altay Kandemir, Mehmet Hadi Yaşa   +6 more
doaj   +1 more source

Current Mesalazine Products: Differences in Enteric-Coated Dosage Forms and Pharmaceutical Risks of Clinical Efficacy Reduction (Review)

Безопасность и риск фармакотерапии
INTRODUCTION. Oral mesalazine (5-aminosalicylic acid) products are commonly used to treat inflammatory bowel disease, in particular,  ulcerative  colitis.
S. Yu. Serebrova, V. V. Evteev, E. Yu. Demchenkova, M. V. Zhuravleva, A. B. Prokofiev   +4 more
doaj   +1 more source

Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome

Clinical and Experimental Gastroenterology, 2011
Andrey E Dorofeyev1, Elena A Kiriyan2, Inna V Vasilenko1, Olga A Rassokhina1, Andrey F Elin11National Medical University, Donetsk, Ukraine; 2Gastroenterological Center of Poltava Hospital Clinic, Poltava, UkraineObjectives: The aim of this study was to ...
Dorofeyev AE, Kiriyan EA, Vasilenko IV, Rassokhina OA, Elin AF   +4 more
doaj  

Mesalazine vs. IBS-D: Examining its Impact on Patient Symptoms & Stool Calprotectin Levels [PDF]

Caspian Journal of Internal Medicine
Background: Irritable bowel syndrome (IBS) is the most common disorder of the gastrointestinal system. The study aimed to determine the effect of Mesalazine prescription on patients' symptoms and level of fecal calprotectin in patients with IBS with ...
Mohammad Hossein Somi, Masood Faghih Dinevari, Behnam Sajedi, Mehdi Rasolimanesh, Faraz Mahdizadeh, Farzad Heydari   +5 more
doaj  

Probiotics and inflammatory bowel disease [PDF]

, 2006
The original publication is available at www.springerlink.com © Springer 2006Gordon S. Howarthhttp://www.springer.com/medicine/internal/book/978-1-4020-5701-
Howarth, G.
core  

PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE: AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL [PDF]

, 2008
Connolly, M, Nielsen, SK, Currie, CJ, Poole, CD   +3 more
core   +1 more source

Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review

Therapeutics and Clinical Risk Management
Juan Pan,1,* Zuyi Li,1,* Chao Ye,2 Xiaojuan Zhang,1 Qiongliang Yang,1 Xu Zhang,1 Ya Zhou,3 Jianjun Zhang2 1Department of Pharmacy, Liuyang Hospital of Traditional Chinese Medicine, Changsha, Hunan, 410300, People’s Republic of China; 2Department ...
Pan J, Li Z, Ye C, Zhang X, Yang Q, Zhang X, Zhou Y, Zhang J   +7 more
doaj  

Risk-stratified pharmacologic strategies for secondary prevention after acute diverticulitis: an exploratory narrative review and research framework. [PDF]

Front Surg
Schiano di Visconte M, Sarnari S, Lo Monaco D, Brillantino A, Marano L, Talento P, Guttadauro A.   +6 more
europepmc   +1 more source